Question 1

What is the Meaning of ICH S1B(R1)?

Accepted Answer

ICH S1B(R1) refers to a specific guideline issued by the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH), titled "Testing for Carcinogenicity of Pharmaceuticals." This guideline provides a globally harmonized, science-based framework for determining when carcinogenicity studies are necessary for new pharmaceutical products, including hormonal agents and peptides. The (R1) denotes a revision to the original guideline, reflecting the continuous effort to refine and modernize drug safety testing by incorporating advancements in molecular science and risk assessment. Adherence to this guideline is mandatory for drug developers seeking regulatory approval in ICH member regions.

Question 2

What is the Origin of ICH S1B(R1)?

Accepted Answer

The ICH was established in 1990 to harmonize regulatory requirements across Europe, Japan, and the United States, reducing the need for redundant testing and streamlining global drug development. The S1 series specifically addresses safety testing. The S1B guideline itself was created to provide clear, consistent criteria for deciding when a two-year rodent carcinogenicity study, a resource-intensive test, is clinically and scientifically warranted.

Question 3

What is the Mechanism of ICH S1B(R1)?

Accepted Answer

The guideline operates by establishing a risk-based decision tree for carcinogenicity testing, moving away from an automatic requirement for all new drugs. It outlines specific triggers that necessitate testing, such as long-term or chronic dosing, evidence of genotoxicity, or structural alerts suggesting carcinogenic potential. The revision, S1B(R1), further incorporates the use of non-genotoxic in vitro and in vivo data, allowing for a weight-of-evidence approach to waive the traditional long-term rodent studies if the risk is deemed negligible. This mechanism ensures rigorous safety assessment while promoting ethical use of animals and accelerating drug development.

ICH S1B(R1)

Meaning

Origin

Mechanism

What Are the Safety Implications of ICH Alignment for Hormonal Therapies?

Provided by the clinical team
at 4Ever Young Miami Dadeland

-15% ∞ HRTIO15

Your protocol begins with a conversation.

Visit

Schedule Appointment

About

Med & Wellness

4Ever Young Miami Dadeland

Communication

+1 786-529-6686

Email Us

Opening Hours